MabVax Therapeutics Holdings Inc. (MBVX) News Nov 14, 2014,

New Post Public Reply Private Reply Replies (0) Message Board

Nov 15, 2014 at 11:21 AM

MabVax Therapeutics Holdings Inc. (MBVX) News Nov 14, 2014, 8:10 p.m.
MarketWatch News on MBVX
Icahn reports no Time-Warner stake; smaller Motorola stake 3:11 p.m. Feb. 14, 2009 - MarketWatch.com
Monday's biggest gaining and declining stocks 3:51 p.m. Oct. 15, 2007 - MarketWatch
Biogen, Genzyme lead biotech stocks higher 10:13 a.m. Oct. 15, 2007 - Val Brickates Kennedy
Telik: FDA removes hold on drug trial 6:46 a.m. Oct. 15, 2007 - Michelle Donley
Telik: FDA ends partial hold on Telcyta clinical development 6:35 a.m. Oct. 15, 2007 - Michael Kitchen
Icahn group discloses investment holdings 7:06 a.m. Aug. 15, 2007 - MarketWatch.com
More biotech partnerships expected 2:40 p.m. June 25, 2007 - Carolyn Pritchard
Tuesday's biggest stock gainers and decliners 4:24 p.m. June 5, 2007 - MarketWatch
Biotech, pharma stocks dip; Telik plunges on FDA woes 12:00 p.m. June 5, 2007 - Val Brickates Kennedy
Telik plunges after FDA halts drug trials 11:58 a.m. June 5, 2007 - Val Brickates Kennedy
Monday's biggest stock gainers and decliners 3:52 p.m. June 4, 2007 - MarketWatch
Biotech, pharma stocks slip on ASCO results 11:04 a.m. June 4, 2007 - Val Brickates Kennedy
Tuesday's biggest stock gainers and decliners 4:43 p.m. April 17, 2007 - Michael Baron
Pharma sector moves higher; J&J's shares gain after results 3:23 p.m. April 17, 2007 - Val Brickates Kennedy
Telik upped to neutral at Janney Montgomery Scott 11:42 a.m. April 17, 2007 - Tomi Kilgore
Telik shares rise on results from Telcyta trial 9:09 a.m. April 17, 2007 - Gabriel Madway
Telik up 24% at $7.30 9:02 a.m. April 17, 2007 - Tomi Kilgore
Stocks in focus for Friday 7:50 p.m. Feb. 22, 2007 - MarketWatch
Updates, advisories and surprises 7:01 p.m. Feb. 22, 2007 - MarketWatch
Telik quarterly loss widens as expenses rise 4:58 p.m. Feb. 22, 2007 - Gabriel Madway
Loading more headlines...
Advertisement
Other News on MBVX
10-Q: MABVAX THERAPEUTICS HOLDINGS, INC. 2:18 p.m. Nov. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-Q: TELIK INC 11:01 a.m. Aug. 8, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-Q: TELIK INC 4:12 p.m. May 15, 2014 - Edgar Online - (EDG = 10Q, 10K)
3 Stocks Raising The Drugs Industry Higher 3:09 p.m. May 13, 2014 - TheStreet.com
Why Telik (TELK) Stock Is Soaring Today 11:06 a.m. May 13, 2014 - TheStreet.com
Telik, Biotech Pariah, Finally Died 5:24 p.m. May 12, 2014 - TheStreet.com
Telik and MabVax tie the reverse merger knot 4:12 p.m. May 12, 2014 - Seeking Alpha
10-K: TELIK INC 3:51 p.m. March 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-Q: TELIK INC 5:02 p.m. Nov. 12, 2013 - Edgar Online - (EDG = 10Q, 10K)
A Look Back At Biotech Short Picks 1:18 p.m. Oct. 31, 2013 - Seeking Alpha
10-Q: TELIK INC 3:43 p.m. Aug. 9, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: TELIK INC 4:10 p.m. May 10, 2013 - Edgar Online - (EDG = 10Q, 10K)
Telik: A Possible Investment, But Only After Much Consideration 12:32 a.m. April 5, 2013 - Seeking Alpha
Is There Value In Telik? 6:18 a.m. Jan. 24, 2013 - Seeking Alpha
4 Healthcare Stock Stories for Wednesday Wellness 4:00 p.m. Jan. 23, 2013 - Wall St. Cheat Sheet
The Long And Short Cases For Telik 11:37 a.m. Jan. 16, 2013 - Seeking Alpha
Between A Rock And A Hard Place: Telik Needs Cash 2:35 p.m. Jan. 14, 2013 - Seeking Alpha
Is It Time To Go Long Or Short Telik? 2:01 a.m. Jan. 13, 2013 - Seeking Alpha
4 Healthcare Stock Stories for Investor Wellbeing 5:46 p.m. Jan. 11, 2013 - Wall St. Cheat Sheet
Is Telik A Good Buy After Increasing 24% In One Day? 4:16 p.m. Dec. 12, 2012 - Seeking Alpha
Loading more headlines...
Press Releases on MBVX
MabVax Therapeutics - "Introducing MabVax Therapeutics: Newly Public Company Achieves Multiple Milestones in Recent Quarter" 7:16 a.m. Oct. 23, 2014 - ACCESSWIRE
MabVax Therapeutics Launches Online Corporate Communication Channels and New Website 7:00 a.m. Oct. 23, 2014 - PR Newswire - PRF
MabVax Therapeutics Nominates The Fully Human Antibody HuMab 5B1 As The Company's Lead Clinical Development Candidate 8:00 a.m. Oct. 21, 2014 - PR Newswire - PRF
MabVax Therapeutics Announces Stock Ticker Symbol Change to MBVX 7:00 a.m. Oct. 10, 2014 - PR Newswire - PRF
MabVax Therapeutics Receives Orphan Drug Designation for Therapeutic Vaccine to Treat Childhood Cancer Neuroblastoma 8:00 a.m. Sept. 25, 2014 - PR Newswire - PRF
MabVax Therapeutics Enters Agreements with Memorial Sloan Kettering Cancer Center and Juno Therapeutics for Development of Anti-Cancer Therapeutics 8:00 a.m. Sept. 10, 2014 - PR Newswire - PRF
MabVax Therapeutics Receives Stockholder Approval for Name Change and Reverse Stock Split Resulting From Merger With Telik 8:00 a.m. Sept. 9, 2014 - PR Newswire - PRF
Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 8:30 a.m. Aug. 28, 2014 - PR Newswire - PRF
Telik Receives $1.5 Million National Cancer Institute Contract to Develop Novel Antibody-based PET Imaging Agent for Pancreatic Cancer 8:30 a.m. Aug. 25, 2014 - PR Newswire - PRF
Telik Announces New Board of Director Members to Oversee Reinvigorated Cancer Therapy Pipeline Resulting from the Recent Merger with MabVax Therapeutics, Inc. 8:00 a.m. Aug. 11, 2014 - PR Newswire - PRF
Telik Announces Plans for Special Meeting of Stockholders and Transition to MabVax Therapeutics Holdings, Inc. 8:00 a.m. Aug. 4, 2014 - PR Newswire - PRF
MabVax Therapeutics Raises $3 Million In Common Stock Financing And An Additional $1.5 Million Upon Exercise Of Series C-1 Warrants 8:30 a.m. July 9, 2014 - PR Newswire - PRF
Telik Announces First Quarter 2014 Financial Results 3:05 p.m. May 15, 2014 - PR Newswire - PRF
Telik and MabVax Therapeutics Announce Definitive Merger Agreement 3:30 p.m. May 12, 2014 - PR Newswire - PRF
MabVax Therapeutics And Telik Sign Definitive Merger Agreement 3:30 p.m. May 12, 2014 - PR Newswire - PRF
Telik Announces Fourth Quarter And 2013 Year End Financial Results 3:15 p.m. March 10, 2014 - PR Newswire - PRF
Telik Announces Third Quarter 2013 Financial Results 4:20 p.m. Nov. 12, 2013 - PR Newswire
Telik Announces Second Quarter 2013 Financial Results 3:15 p.m. Aug. 9, 2013 - PR Newswire
Telik Announces First Quarter 2013 Financial Results 3:30 p.m. May 10, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Humberto Quintanar Strengthens McKinley Irvin's Seattle Team

Humberto Quintanar Makes His Move In a world where legal battles can shake lives to the core, McKinley Irvin is throwing another heavyweight into the ring. They’ve just pulled in Humberto Quintanar, a guy who knows his way around a courtroom like a cabbie knows a city's backstreets. This isn't just another seat-fillin' lawyer; Quintanar packs years of experience as a...

Approved Oil Secures Long-Term NYC Fuel Terminal Deal

Approved Oil Locks in Future with Sunoco Deal Amidst the contraction of New York City's fuel terminal landscape, securing a consistent lifeline to crucial infrastructure feels like striking gold. Approved Oil just locked down an agreement with Sunoco for a new terminal location that'll last deep into the 2040s, and it's about more than just securing a spot on the...

Columbia Distributing Expands to Alaska: A Growth Move

Alaska's Entry: Columbia's New Frontier When Columbia Distributing dives into a new territory, you know they're serious about growth. This latest move sees them planting their flag in Alaska, finally completing a strategic vision that's been brewing for a while. Four-State Strategy Comes to Fruition The transaction with Republic National Distributing Company (RNDC) is no...

Gildan's Troubling Legal Struggles: Investor Action Alert

Gildan's Bumpy Ride: Legal Woes Unfold Well, folks, seems like Gildan Activewear Inc. (NYSE:GIL) is in for a bumpy ride, and not the kind that makes you feel alive, I tell ya. They've been slapped with a class action lawsuit, and the news ain't pretty. Accusations are flying hot about how they've been playing fast and loose with their financials. The Allegations: Channel...

DropGenie Nets $5M to Boost Functional Biology Reach

DropGenie Scores Big with Fresh Financing Boost Out of the Montreal wilderness, DropGenie is charging forward with a fresh $5 million injection in Seed+ financing. This isn't just loose change; it's a ticket to accelerating their mission of advancing functional biology platforms and beefing up data partnerships. You know, the kind of partnerships that even the suits in...

Skechers Facing Class Action: Investors Urged to Act

Skechers Under Fire: Fraud Allegations Surface Alright, if you've been around the stock block a while, you know these stories can often read like a suspense novel. Plot twist: Skechers U.S.A., Inc. (formerly NYSE: SKX) is now facing some serious accusations. There's a class action lawsuit claiming that some shady dealings went down during the company's $9.4 billion...

Cumberland Pharmaceuticals Eyes NDA for Ifetroban in DMD

Rolling the Dice with Ifetroban There's a buzz in the air around Cumberland Pharmaceuticals as they gear up to tackle one of medicine's stubborn giants, Duchenne muscular dystrophy (DMD). They plan to file a New Drug Application (NDA) with the FDA for ifetroban, aiming to treat the cardiomyopathy plaguing many DMD sufferers. Folks who’ve watched Cumberland (NASDAQ:CPIX)...

Ernesta Expands Southeast Reach with Atlanta Showroom

Ernesta's Southeast Play: The Atlanta Showroom Here's something to turn heads in the world of custom home design—Ernesta has just set up shop in Atlanta, a move that speaks volumes about their ambitions in the Southeast market. This isn't just about selling a few more rugs; it's a calculated step into a region ripe with design potential and a hunger for bespoke home...

Gildan Activewear Faces Major Class Action Lawsuit

Investors Turn Against Gildan Activewear Ever see a freight train barreling down the track? That's what it feels like when a class action lawsuit rears its head against a behemoth like Gildan Activewear Inc. (NYSE: GIL). After years of allegedly pulling the wool over investors' eyes, those same investors are now being called to muster—their chance to lead a charge of...

Bertram Capital Backs MCE's Expansive Growth Vision

A Strategic Move for Bertram Capital Right on the heels of seasoned market moves, Bertram Capital has thrown its support behind Motion & Control Enterprises (MCE). This isn't just another portfolio addition; it's a calculated step into the complex world of industrial distribution, partnering with a company renowned for its prowess in engineered solutions. If you've ever...